Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 8,815,526 · Class: 7.6%
- Morgan Stanley Capital Services LLC
Shares: 8,469,117 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000194
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Feb 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership